Fennec Pharmaceuticals Inc. · NASDAQ:FENC

Hackman Jeffrey S. received 1,159 Fennec Pharmaceuticals Inc. shares as an award (Form 4)

Traded Sep 30, 2026 · Filed Oct 1, 2026

On Sep 30, 2026, Hackman Jeffrey S. (Director, Chief Executive Officer) received 1,159 Fennec Pharmaceuticals Inc. shares as an award, leaving 67,461 shares. Filed Oct 1, 2026 (Form 4).

Awarded
1,159 shares
Holding after
67,461 shares
Trading plan
No
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 30, 2026Common SharesAward1,15967,461Direct

Source

View original at SEC

Related